GLP-1 Receptor Agonists: Overcoming Barriers (Podcast) is organized by Pri-Med.

Release Date: 11/16/2020
Expiration Date: 11/16/2021

Accreditation:
Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

This program has been approved for 0.25 contact hour of continuing education, which includes 0.25 hour of pharmacology.

Topics: Diabetes, Cardiovascular Outcomes Trials, Cardiovascular Risk in Diabetes, GLP-1 Receptor Agonists, Diabetes Mellitus, Type 2

Overview:
With the growing role of GLP-1 RAs in the management of diabetes, primary care providers are likely to find themselves discussing this class of medications with their patients. In this podcast, Dr. Michelle Magee will focus on barriers that patients may face to starting a GLP-1 RA and common questions that emerge in patient teaching. Faculty will review ways to troubleshoot these challenges and empower the clinician to engage in effective dialogue around this drug class.

Learning Objectives:
• Distinguish among the available GLP-1 RAs based on mode of administration, duration of action, and renal dosing
• Apply data on cardiovascular risk reduction demonstrated by individual GLP-1 RAs into practice
• Evaluate the appropriate use of GLP-1 RAs in special populations

Additional details will be posted as soon as information is available.